Assignee
MESSAGE PHARMACEUTICALS
US·7 granted patents·155 citations·filing 1997–2002
Top patents by PatentIndex Score
7 records- 0190US6630589B1Identification of compounds for the treatment or prevention of proliferative diseasesMESSAGE PHARMACEUTICALS·Filed 2002·Granted Oct 7, 2003·32 cites·34 claims
- 0289US6936432B2Bacterial RNase P proteins and their use in identifying antibacterial compoundsMESSAGE PHARMACEUTICALS·Filed 2001·Granted Aug 30, 2005·37 cites·15 claims
- 0383US6872850B2Small molecule inhibitors of secretion of proteins encoded by ARE-mRNAsMESSAGE PHARMACEUTICALS·Filed 2002·Granted Mar 29, 2005·15 cites·8 claims
- 0483US6448007B1Functional genomic screen for post-transcriptional 5′ and 3′ regulatory elementsMESSAGE PHARMACEUTICALS·Filed 2000·Granted Sep 10, 2002·17 cites·33 claims
- 0575US7001924B2Inhibitors of RNase P proteins as antibacterial compoundsMESSAGE PHARMACEUTICALS·Filed 2002·Granted Feb 21, 2006·11 cites·27 claims
- 0671US6004749AMethod for identifying compounds affecting RNA/RNA binding protein interactionsMESSAGE PHARMACEUTICALS·Filed 1997·Granted Dec 21, 1999·42 cites·22 claims
- 0759US7037660B2Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acidsMESSAGE PHARMACEUTICALS·Filed 2002·Granted May 2, 2006·1 cites·41 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →